Flipside Finance
AZ

AstraZeneca PLC

AZNEquity
$156.53-0.24%
24h Volume: $0.00B

AI Summary

Updated 5h ago

AstraZeneca PLC (AZN) is experiencing elevated selling pressure

AstraZeneca PLC (AZN) is experiencing elevated selling pressure. Flow indicators are at historically low levels — capital has been moving out of this asset over the recent period. For reference: Flow Score 21/100, Trend & Momentum Score 20/100.

15Low
Market position

Market Positioning

14Compressed
Extension
16Washed out
Momentum
14Outflow
Flow
29Below avg
Volatility

The Bigger Picture

Updated 2d ago
Macro context will be updated shortly
Flow Score: 23/100Trend Score: 21/1003-Month Return: -17.5%

Technical Analysis

Market Positioning

Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.

Extension
[avg: 14th]
14thpercentile
Low
Normal
High
14th percentile
Momentum
[avg: 16th]
16thpercentile
Low
Normal
High
16th percentile
Flow
[avg: 14th]
14thpercentile
Low
Normal
High
14th percentile
Volatility
[avg: 29th]
29thpercentile
Low
Normal
High
29th percentile

Key Levels

Demand: $153–$156 (1.3% below)
score: 3.54
Supply: $162–$167 (4.5% above)
score: 3.05
View full Key Levels section →

Looking at the full picture for AstraZeneca PLC (AZN): extension is deeply below average — at historically low levels (14th percentile), momentum is below average (16th percentile), flow is deeply below average — at historically low levels (14th percentile), volatility is below average (29th percentile). All three directional dimensions — extension, momentum, and flow — are in the lower portion of their historical ranges. The asset is under broad pressure, with price compressed, upward energy depleted, and selling pressure elevated. There is no positive divergence to point to. The key to watch is whether flow stabilises above the 40th percentile while extension remains compressed. That combination would represent a historically more significant setup.

Conclusion

AstraZeneca PLC (AZN) is under broad pressure across multiple dimensions — extension, momentum, and flow are all in the lower portion of their historical ranges. There is no positive divergence to point to at this stage. If extension drops further into the lower teens while flow holds above the 40th percentile, that would represent a historically more significant setup. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.

Your portfolio. Your context. Smarter decisions.

Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.

AI + Portfolio

Personalized insights based on your actual holdings

Daily Briefing

Major market movements delivered to your inbox

Watchlists

Track the assets that matter most to you

Create your free account

No credit card required